Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Thiazole, a sulfur and nitrogen chemical, is useful in creating potential drugs for conditions like seizures, cancer, bacterial infections, tuberculosis, inflammation, malaria, viruses, Alzheimer's, diabetes, and A1-receptor issues.

5-Bromo-3,4-dihydroxybenzaldehyde could potentially help hair growth by activating certain cell pathways and inhibiting others.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

N13-substituted evodiamine derivatives improved anticancer activity and solubility, showing promise for drug development.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Compound 15a was effective in inhibiting 5α-reductase.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

A new compound was made that might help treat diseases related to male hormones.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

A new method creates valuable compounds for drug discovery by breaking traditional chemical rules.

Four-amino acid part makes enzyme sensitive to finasteride.

New compounds show promise as nonsteroidal treatments for hair loss.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Three methods accurately measure finasteride in tablets using dyes and bromate-bromide.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

A new compound that could treat various androgen-related conditions was created and analyzed.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

A new method accurately measures finasteride in tablets using color change and light absorption.

Finasteride's molecular properties and active sites were identified using computational methods.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

A new method creates unique chemical structures that could improve drug discovery.

The MXD/24HA salt is more effective for hair growth than raw MXD.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Metabolite 7 is a strong inhibitor for Alzheimer's disease management.

A new method efficiently modifies alkenes to create useful medicinal compounds.